Polymer Carriers for Anticancer Drugs Targeted to EGF Receptor

Macromolecular Bioscience

Volumn 12, Issue 12, 2012, Pages 1714-1720

  Studenovsky, Martin ^a   Pola, Robert ^a   Pechar, Michal ^a   Etrych, Tomas ^a   Ulbrich, Karel ^a   Kovar, Lubomir ^b   Kabesova, Martina ^b   Rihova, Blanka ^b  

^a INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

^b INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Biocompatibility; EGFR; Peptides; Polymer conjugates; Tumor drug delivery

Indexed keywords

ANTICANCER DRUG; BINDING ACTIVITIES; CELL LINES; EGFR; EPR EFFECT; METHACRYLAMIDES; OLIGOPEPTIDE SEQUENCES; POLYMER CARRIER; POLYMER CONJUGATE; POLYMER THERAPEUTICS; TUMOR CELLS;

BIOCOMPATIBILITY; CELL CULTURE; DRUG DELIVERY; PEPTIDES; TUMORS;

FUNCTIONAL POLYMERS;

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORESCENT DYE; GE7 PEPTIDE; N (2 HYDROXYPROPYL)METHACRYLAMIDE COPOLYMER; OLIGOPEPTIDE; PEPTIDE FRAGMENT; SCR1 PEPTIDE; SCR2 PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG BINDING; DRUG CONJUGATION; DRUG PENETRATION; DRUG RETENTION; DRUG TARGETING; FLUORESCENCE; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; TUMOR CELL;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; HUMANS; OLIGOPEPTIDES; POLYMETHACRYLIC ACIDS; POSITRON-EMISSION TOMOGRAPHY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 84872369269     PISSN: 16165187     EISSN: 16165195     Source Type: Journal    
DOI: 10.1002/mabi.201200270     Document Type: Article

References (21)

1. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, K. Hori, J. Controlled Release 2000, 65, 271.
2. Y. Matsumura, H. Maeda, Cancer Res. 1986, 46, 6387.
3. L. W. Seymour, Y. Miyamoto, H. Maeda, M. Brereton, J. Strohalm, K. Ulbrich, R. Duncan, Eur. J. Cancer 1995, 31, 766.
4. T. Etrych, L. Kovar, J. Strohalm, P. Chytil, B. Rihova, K. Ulbrich, J. Controlled Release 2011, 154, 241.
5. O. H. Aina, T. C. Sroka, M. L. Chen, K. S. Lam, Biopolymers 2002, 66, 184.
6. P. Alessi, C. Ebbinghaus, D. Neri, BBA-Rev. Cancer 2004, 1654, 39.
7. R. Satchi-Fainaro, R. Duncan, C. M. Barnes, Adv. Polym. Sci. 2006, 193, 1.
8. S. M. Huang, P. M. Harari, Invest. New Drugs 1999, 17, 259.
9. S. E. Kane, Expert. Opin. Ther. Patents 2006, 16, 147.
10. X. Liu, P. K. Tian, D. W. Ju, M. H. Zhang, M. Yao, X. T. Xue-Tao Cao, J. R. Gu, Cancer Gene Ther. 2003, 10, 529.
11. B. Rihova, K. Ulbrich, J. Strohalm, V. Vetvicka, M. Bilej, J. Kopecek, R. Duncan, Biomaterials 1989, 10, 335.
12. V. Subr, K. Ulbrich, React. Funct. Polym. 2006, 66, 1525.
13. K. Ulbrich, V. Subr, J. Strohalm, D. Plocova, M. Jelinkova, B. Rihova, J. Controlled Release 2000, 64, 63.
14. R. Pola, M. Studenovsky, M. Pechar, K. Ulbrich, O. Hovorka, D. Vetvicka, B. Rihova, J. Drug Targeting 2009, 17, 773.
15. W. Eicheler, M. Krause, F. Hessel, D. Zips, M. Baumann, Radiother. Oncol. 2005, 76, 151.
16. K. Subik, J. F. Lee, L. Baxter, T. Strzepek, D. Costello, P. Crowley, L. Xing, M. C. Hung, T. Bonfiglio, D. G. Hicks, P. Tang, Breast Cancer: Basic Clin. Res. 2010, 4, 35.
17. D. Balin-Gauthier, J. P. Delord, P. Rochaix, V. Mallard, F. Thomas, I. Hennebelle, R. Bugat, P. Canal, C. Allal, Cancer Chemother. Pharm. 2006, 57, 709.
18. A. Diaz, E. Suarez, R. Blanco, A. Lopez, E. Montero, Front. Biosci. 2009, 14, 159.
19. W. C. Chan, P. D. White, Fmoc Solid Phase Peptide Synthesis - A Practical Approach, Oxford University Press, Oxford 2000.
20. M. Pechar, R. Pola, R. Laga, K. Ulbrich, L. Bednarova, P. Malon, I. Sieglova, V. Kral, M. Fabry, O. Vanek, Biomacromolecules 2011, 12, 3645.
21. R. Pola, M. Pechar, K. Ulbrich, A. Fabra Fres, J. Bioact. Compat. Polym. 2007, 22, 602.